Skip to main content
Unicycive Therapeutics, Inc. logo

Unicycive Therapeutics, Inc. — Investor Relations & Filings

Ticker · UNCY ISIN · US90460M2044 US Manufacturing
Filings indexed 270 across all filing types
Latest filing 2026-05-12 Regulatory Filings
Country US United States of America
Listing US UNCY

About Unicycive Therapeutics, Inc.

https://unicycive.com/

Unicycive Therapeutics, Inc. is a clinical-stage biotechnology company that develops novel treatments for kidney diseases. The company is focused on addressing unmet medical needs in nephrology by advancing a pipeline of therapeutic candidates. Its lead investigational product is oxylanthanum carbonate (OLC), a next-generation phosphate binding agent for the treatment of hyperphosphatemia in patients with chronic kidney disease (CKD). Unicycive aims to accelerate the development of innovative medicines to improve the quality of life for patients suffering from kidney-related conditions.

Recent filings

Filing Released Lang Actions
8-K - Unicycive Therapeutics, Inc. (0001766140) (Filer)
Regulatory Filings
2026-05-12 English
10-Q - Unicycive Therapeutics, Inc. (0001766140) (Filer)
Interim / Quarterly Report
2026-05-12 English
ARS - Unicycive Therapeutics, Inc. (0001766140) (Filer)
Annual Report
2026-04-30 English
DEF 14A - Unicycive Therapeutics, Inc. (0001766140) (Filer)
Proxy Solicitation & Information Statement
2026-04-30 English
8-K - Unicycive Therapeutics, Inc. (0001766140) (Filer)
Regulatory Filings
2026-04-06 English
8-K - Unicycive Therapeutics, Inc. (0001766140) (Filer)
Regulatory Filings
2026-03-30 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.